170 related articles for article (PubMed ID: 20804521)
1. Idiopathic intracranial hypertension in the USA: the role of obesity in establishing prevalence and healthcare costs.
Friesner D; Rosenman R; Lobb BM; Tanne E
Obes Rev; 2011 May; 12(5):e372-80. PubMed ID: 20804521
[TBL] [Abstract][Full Text] [Related]
2. The relationship between idiopathic intracranial hypertension and obesity.
Hannerz J; Ericson K
Headache; 2009 Feb; 49(2):178-84. PubMed ID: 19222591
[TBL] [Abstract][Full Text] [Related]
3. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
Wolfenstetter SB
Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
[TBL] [Abstract][Full Text] [Related]
4. The cost of obesity in Canada.
Birmingham CL; Muller JL; Palepu A; Spinelli JJ; Anis AH
CMAJ; 1999 Feb; 160(4):483-8. PubMed ID: 10081464
[TBL] [Abstract][Full Text] [Related]
5. The incidence and prevalence of idiopathic intracranial hypertension in Sheffield, UK.
Raoof N; Sharrack B; Pepper IM; Hickman SJ
Eur J Neurol; 2011 Oct; 18(10):1266-8. PubMed ID: 21426442
[TBL] [Abstract][Full Text] [Related]
6. Plasma ghrelin levels are normal in obese patients with idiopathic intracranial hypertension (pseudotumor cerebri).
Subramanian PS; Goldenberg-Cohen N; Shukla S; Cheskin LJ; Miller NR
Am J Ophthalmol; 2004 Jul; 138(1):109-13. PubMed ID: 15234288
[TBL] [Abstract][Full Text] [Related]
7. Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri).
Daniels AB; Liu GT; Volpe NJ; Galetta SL; Moster ML; Newman NJ; Biousse V; Lee AG; Wall M; Kardon R; Acierno MD; Corbett JJ; Maguire MG; Balcer LJ
Am J Ophthalmol; 2007 Apr; 143(4):635-41. PubMed ID: 17386271
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis and systematic review of population-based epidemiological studies in idiopathic intracranial hypertension.
McCluskey G; Doherty-Allan R; McCarron P; Loftus AM; McCarron LV; Mulholland D; McVerry F; McCarron MO
Eur J Neurol; 2018 Oct; 25(10):1218-1227. PubMed ID: 29953685
[TBL] [Abstract][Full Text] [Related]
9. Obesity and overweight in Canada: an updated cost-of-illness study.
Anis AH; Zhang W; Bansback N; Guh DP; Amarsi Z; Birmingham CL
Obes Rev; 2010 Jan; 11(1):31-40. PubMed ID: 19413707
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic intracranial hypertension: can studies of obesity provide the key to understanding pathogenesis?
Ooi LY; Walker BR; Bodkin PA; Whittle IR
Br J Neurosurg; 2008 Apr; 22(2):187-94. PubMed ID: 18348012
[TBL] [Abstract][Full Text] [Related]
11. Health economics of weight management: evidence and cost.
Kouris-Blazos A; Wahlqvist ML
Asia Pac J Clin Nutr; 2007; 16 Suppl 1():329-38. PubMed ID: 17392129
[TBL] [Abstract][Full Text] [Related]
12. Healthcare utilization and costs of patients with rosacea in an insured population.
Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic intracranial hypertension is associated with lower body adiposity.
Kesler A; Kliper E; Shenkerman G; Stern N
Ophthalmology; 2010 Jan; 117(1):169-74. PubMed ID: 19913917
[TBL] [Abstract][Full Text] [Related]
14. [The cost of obesity on the Danish health care system].
Worre-Jensen AL; Jensen NB; Heitmann BL; Sørensen TI
Ugeskr Laeger; 2007 Aug; 169(33):2634-7. PubMed ID: 17725912
[TBL] [Abstract][Full Text] [Related]
15. The expanding burden of idiopathic intracranial hypertension.
Mollan SP; Aguiar M; Evison F; Frew E; Sinclair AJ
Eye (Lond); 2019 Mar; 33(3):478-485. PubMed ID: 30356129
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic Intracranial Hypertension in the Northwest of Northern Ireland: Epidemiology and Clinical Management.
McCluskey G; Mulholland DA; McCarron P; McCarron MO
Neuroepidemiology; 2015; 45(1):34-9. PubMed ID: 26201454
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic intracranial hypertension: associations with coagulation disorders and polycystic-ovary syndrome.
Glueck CJ; Iyengar S; Goldenberg N; Smith LS; Wang P
J Lab Clin Med; 2003 Jul; 142(1):35-45. PubMed ID: 12878984
[TBL] [Abstract][Full Text] [Related]
18. Population-based incidence and clinical characteristics of idiopathic intracranial hypertension.
Sundholm A; Burkill S; Sveinsson O; Piehl F; Bahmanyar S; Nilsson Remahl AIM
Acta Neurol Scand; 2017 Nov; 136(5):427-433. PubMed ID: 28244170
[TBL] [Abstract][Full Text] [Related]
19. Re-evaluating the Incidence of Idiopathic Intracranial Hypertension in an Era of Increasing Obesity.
Kilgore KP; Lee MS; Leavitt JA; Mokri B; Hodge DO; Frank RD; Chen JJ
Ophthalmology; 2017 May; 124(5):697-700. PubMed ID: 28187976
[TBL] [Abstract][Full Text] [Related]
20. The obesity-driven rising costs of type 2 diabetes in Australia: projections from the Fremantle Diabetes Study.
Davis WA; Knuiman MW; Hendrie D; Davis TM
Intern Med J; 2006 Mar; 36(3):155-61. PubMed ID: 16503950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
